Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

A 25-Year Retrospective on the Public's Perception of the Biopharmaceutical and Biotech Industry

March 1, 2012

This month, we rewind to an article titled "Demystifying the New Biology."

Putting Risk-Based Decision-Making Where It Belongs

March 1, 2012

Focusing on how risk affects the entire organization can improve the business bottom line.

Sustainable Investment

February 1, 2012

Industry announces plans for year ahead at annual JPMorgan Global Healthcare Conference.

The Drive for Best Practice in Biopharmaceutical Manufacturing

February 1, 2012

Introducing a new way to think about sharing information in a patent-driven industry.

Here's to a Year of Compromise

January 1, 2012

The benefits of harmonization may be on industry's wish list, but buying into change is another story.

Global Economic Woes Overshadow Biotech Industry Advances in 2011

January 1, 2012

Greater emphasis on focus and efficiency for companies as market demands value in 2012.

Supporting Innovation Requires Consistency and Vision

December 1, 2011

Political leaders need to consider the impact of the biopharmaceutical industry on the economy.

Navigating the Biosimilars Market

September 2, 2011

The market landscape for biosimilars is in flux, with limited penetration now, but with the potential for growth for those who can navigate the market. Plus: A SWOT analysis of biosimilars by Anjan Selz.

Trends in Prefills

September 2, 2011

An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.

ADVERTISEMENT

ADVERTISEMENT

Click here